Increased expression of epithelial GSDMD is observed in patients with IBD and experimental colitis model animals, and the epithelial-derived GSDMD mediates the release of insoluble IL-1β during experimental colitis [75]. This evidence concerns the gene IL1B and inflammatory bowel disease.